Table of Content

1 Parkinson's Disease (PD) Drugs Market Overview
1.1 Parkinson's Disease (PD) Drugs Product Scope
1.2 Parkinson's Disease (PD) Drugs Segment by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Parkinson's Disease (PD) Drugs Segment by Application
1.3.1 Global Parkinson's Disease (PD) Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Family
1.4 Parkinson's Disease (PD) Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Parkinson's Disease (PD) Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Parkinson's Disease (PD) Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Parkinson's Disease (PD) Drugs Price Trends (2016-2027)

2 Parkinson's Disease (PD) Drugs Estimates and Forecasts by Region
2.1 Global Parkinson's Disease (PD) Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027)
2.4.3 China Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027)
2.4.6 India Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027)

3 Global Parkinson's Disease (PD) Drugs Competition Landscape by Players
3.1 Global Top Parkinson's Disease (PD) Drugs Players by Sales (2016-2021)
3.2 Global Top Parkinson's Disease (PD) Drugs Players by Revenue (2016-2021)
3.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020)
3.4 Global Parkinson's Disease (PD) Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Parkinson's Disease (PD) Drugs Market Size by Type
4.1 Global Parkinson's Disease (PD) Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Parkinson's Disease (PD) Drugs Price by Type (2016-2021)
4.2 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2022-2027)

5 Global Parkinson's Disease (PD) Drugs Market Size by Application
5.1 Global Parkinson's Disease (PD) Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Parkinson's Disease (PD) Drugs Price by Application (2016-2021)
5.2 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Parkinson's Disease (PD) Drugs Price Forecast by Application (2022-2027)

6 North America Parkinson's Disease (PD) Drugs Market Facts & Figures
6.1 North America Parkinson's Disease (PD) Drugs Sales by Company
6.1.1 North America Parkinson's Disease (PD) Drugs Sales by Company (2016-2021)
6.1.2 North America Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021)
6.2 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type
6.2.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application
6.3.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2022-2027)

7 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures
7.1 Europe Parkinson's Disease (PD) Drugs Sales by Company
7.1.1 Europe Parkinson's Disease (PD) Drugs Sales by Company (2016-2021)
7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021)
7.2 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type
7.2.1 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Parkinson's Disease (PD) Drugs Market Facts & Figures
8.1 China Parkinson's Disease (PD) Drugs Sales by Company
8.1.1 China Parkinson's Disease (PD) Drugs Sales by Company (2016-2021)
8.1.2 China Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021)
8.2 China Parkinson's Disease (PD) Drugs Sales Breakdown by Type
8.2.1 China Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027)
8.3 China Parkinson's Disease (PD) Drugs Sales Breakdown by Application
8.3.1 China 167 Sales Breakdown by Application (2016-2021)
8.3.2 China 167 Sales Breakdown by Application (2022-2027)

9 Japan Parkinson's Disease (PD) Drugs Market Facts & Figures
9.1 Japan Parkinson's Disease (PD) Drugs Sales by Company
9.1.1 Japan Parkinson's Disease (PD) Drugs Sales by Company (2016-2021)
9.1.2 Japan Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021)
9.2 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Type
9.2.1 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Parkinson's Disease (PD) Drugs Market Facts & Figures
10.1 Southeast Asia Parkinson's Disease (PD) Drugs Sales by Company
10.1.1 Southeast Asia Parkinson's Disease (PD) Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Parkinson's Disease (PD) Drugs Market Facts & Figures
11.1 India Parkinson's Disease (PD) Drugs Sales by Company
11.1.1 India Parkinson's Disease (PD) Drugs Sales by Company (2016-2021)
11.1.2 India Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021)
11.2 India Parkinson's Disease (PD) Drugs Sales Breakdown by Type
11.2.1 India Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027)
11.3 India Parkinson's Disease (PD) Drugs Sales Breakdown by Application
11.3.1 India Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Parkinson's Disease (PD) Drugs Business
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Business Overview
12.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Business Overview
12.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
12.3.5 Novartis Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Corporation Information
12.4.2 Teva Pharmaceutical Industries Business Overview
12.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Business Overview
12.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
12.5.5 AbbVie Recent Development
12.6 Abital Pharma
12.6.1 Abital Pharma Corporation Information
12.6.2 Abital Pharma Business Overview
12.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
12.6.5 Abital Pharma Recent Development
12.7 Addex Therapeutics
12.7.1 Addex Therapeutics Corporation Information
12.7.2 Addex Therapeutics Business Overview
12.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
12.7.5 Addex Therapeutics Recent Development
12.8 Biogen
12.8.1 Biogen Corporation Information
12.8.2 Biogen Business Overview
12.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
12.8.5 Biogen Recent Development
12.9 Eisai
12.9.1 Eisai Corporation Information
12.9.2 Eisai Business Overview
12.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
12.9.5 Eisai Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Corporation Information
12.10.2 Eli Lilly Business Overview
12.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
12.10.5 Eli Lilly Recent Development
12.11 F. Hoffmann-La Roche
12.11.1 F. Hoffmann-La Roche Corporation Information
12.11.2 F. Hoffmann-La Roche Business Overview
12.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products Offered
12.11.5 F. Hoffmann-La Roche Recent Development
12.12 H. Lundbeck
12.12.1 H. Lundbeck Corporation Information
12.12.2 H. Lundbeck Business Overview
12.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Products Offered
12.12.5 H. Lundbeck Recent Development
12.13 Impax Laboratories
12.13.1 Impax Laboratories Corporation Information
12.13.2 Impax Laboratories Business Overview
12.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Products Offered
12.13.5 Impax Laboratories Recent Development
12.14 Kyowa Hakko Kirin
12.14.1 Kyowa Hakko Kirin Corporation Information
12.14.2 Kyowa Hakko Kirin Business Overview
12.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Products Offered
12.14.5 Kyowa Hakko Kirin Recent Development
12.15 Otsuka Pharmaceutical
12.15.1 Otsuka Pharmaceutical Corporation Information
12.15.2 Otsuka Pharmaceutical Business Overview
12.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Products Offered
12.15.5 Otsuka Pharmaceutical Recent Development
12.16 Pfizer
12.16.1 Pfizer Corporation Information
12.16.2 Pfizer Business Overview
12.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Pfizer Parkinson's Disease (PD) Drugs Products Offered
12.16.5 Pfizer Recent Development

13 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
13.1 Parkinson's Disease (PD) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
13.4 Parkinson's Disease (PD) Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Parkinson's Disease (PD) Drugs Distributors List
14.3 Parkinson's Disease (PD) Drugs Customers

15 Market Dynamics
15.1 Parkinson's Disease (PD) Drugs Market Trends
15.2 Parkinson's Disease (PD) Drugs Drivers
15.3 Parkinson's Disease (PD) Drugs Market Challenges
15.4 Parkinson's Disease (PD) Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Parkinson's Disease (PD) Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Parkinson's Disease (PD) Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Parkinson's Disease (PD) Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Region (2016-2021)
Table 5. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Parkinson's Disease (PD) Drugs Revenue Share by Region (2016-2021)
Table 8. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Parkinson's Disease (PD) Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Parkinson's Disease (PD) Drugs Sales Share by Company (2016-2021)
Table 14. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Parkinson's Disease (PD) Drugs Revenue Share by Company (2016-2021)
Table 16. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020)
Table 17. Global Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2016-2021)
Table 22. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table 23. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2022-2027)
Table 26. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2022-2027)
Table 28. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2016-2021)
Table 30. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Table 31. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2022-2027)
Table 34. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2022-2027)
Table 35. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2022-2027)
Table 37. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 39. North America Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027)
Table 62. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 63. China Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021)
Table 64. China Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 67. China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 68. China Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 69. China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027)
Table 70. China Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 71. China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 72. China Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 73. China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027)
Table 98. India Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 99. India Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021)
Table 100. India Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 103. India Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 104. India Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 105. India Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027)
Table 106. India Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 107. India Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 108. India Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 109. India Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027)
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 114. Boehringer Ingelheim Recent Development
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Business Overview
Table 117. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product
Table 119. GlaxoSmithKline Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Novartis Parkinson's Disease (PD) Drugs Product
Table 124. Novartis Recent Development
Table 125. Teva Pharmaceutical Industries Corporation Information
Table 126. Teva Pharmaceutical Industries Description and Business Overview
Table 127. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product
Table 129. Teva Pharmaceutical Industries Recent Development
Table 130. AbbVie Corporation Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. AbbVie Parkinson's Disease (PD) Drugs Product
Table 134. AbbVie Recent Development
Table 135. Abital Pharma Corporation Information
Table 136. Abital Pharma Description and Business Overview
Table 137. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Abital Pharma Parkinson's Disease (PD) Drugs Product
Table 139. Abital Pharma Recent Development
Table 140. Addex Therapeutics Corporation Information
Table 141. Addex Therapeutics Description and Business Overview
Table 142. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Addex Therapeutics Parkinson's Disease (PD) Drugs Product
Table 144. Addex Therapeutics Recent Development
Table 145. Biogen Corporation Information
Table 146. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Biogen Description and Business Overview
Table 148. Biogen Parkinson's Disease (PD) Drugs Product
Table 149. Biogen Recent Development
Table 150. Eisai Corporation Information
Table 151. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Eisai Description and Business Overview
Table 153. Eisai Parkinson's Disease (PD) Drugs Product
Table 154. Eisai Recent Development
Table 155. Eli Lilly Corporation Information
Table 156. Eli Lilly Description and Business Overview
Table 157. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Eli Lilly Parkinson's Disease (PD) Drugs Product
Table 159. Eli Lilly Recent Development
Table 160. F. Hoffmann-La Roche Corporation Information
Table 161. F. Hoffmann-La Roche Description and Business Overview
Table 162. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product
Table 164. F. Hoffmann-La Roche Recent Development
Table 165. H. Lundbeck Corporation Information
Table 166. H. Lundbeck Description and Business Overview
Table 167. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. H. Lundbeck Parkinson's Disease (PD) Drugs Product
Table 169. H. Lundbeck Recent Development
Table 170. Impax Laboratories Corporation Information
Table 171. Impax Laboratories Description and Business Overview
Table 172. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Impax Laboratories Parkinson's Disease (PD) Drugs Product
Table 174. Impax Laboratories Recent Development
Table 175. Kyowa Hakko Kirin Corporation Information
Table 176. Kyowa Hakko Kirin Description and Business Overview
Table 177. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product
Table 179. Kyowa Hakko Kirin Recent Development
Table 180. Otsuka Pharmaceutical Corporation Information
Table 181. Otsuka Pharmaceutical Description and Business Overview
Table 182. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product
Table 184. Otsuka Pharmaceutical Recent Development
Table 185. Pfizer Corporation Information
Table 186. Pfizer Description and Business Overview
Table 187. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Pfizer Parkinson's Disease (PD) Drugs Product
Table 189. Pfizer Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Parkinson's Disease (PD) Drugs Distributors List
Table 193. Parkinson's Disease (PD) Drugs Customers List
Table 194. Parkinson's Disease (PD) Drugs Market Trends
Table 195. Parkinson's Disease (PD) Drugs Market Drivers
Table 196. Parkinson's Disease (PD) Drugs Market Challenges
Table 197. Parkinson's Disease (PD) Drugs Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Product Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Dopamine Agonist Product Picture
Figure 4. Monoamine Oxidase Inhibitors Product Picture
Figure 5. Acetylcholinesterase Inhibitors Product Picture
Figure 6. Glutamate Inhibitors Product Picture
Figure 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2021 & 2027
Figure 8. Hospital Examples
Figure 9. Family Examples
Figure 10. Global Parkinson's Disease (PD) Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Parkinson's Disease (PD) Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 13. Global Parkinson's Disease (PD) Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Parkinson's Disease (PD) Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Europe Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Parkinson's Disease (PD) Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue in Parkinson's Disease (PD) Drugs: 2016 & 2020
Figure 29. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2016-2021)
Figure 31. Global Parkinson's Disease (PD) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2016-2021)
Figure 33. Global Parkinson's Disease (PD) Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 35. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020
Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 37. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020
Figure 38. China Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 39. China Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020
Figure 40. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 41. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020
Figure 42. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 43. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020
Figure 44. India Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 45. India Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Parkinson's Disease (PD) Drugs
Figure 48. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
Figure 49. Parkinson's Disease (PD) Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed